The syndrome, which causes prolonged and severe fatigue, body aches and other symptoms, has long been a mystery ailment, and patients have sometimes been suspected of malingering or having psychiatric problems rather than genuine physical ones. Worldwide, 17 million people have the syndrome, including at least one million Americans.
An article published online Thursday in the journal Science reports that 68 of 101 patients with the syndrome, or 67 percent, were infected with an infectious virus, xenotropic murine leukemia virus-related virus, or XMRV. By contrast, only 3.7 percent of 218 healthy people were infected. Continuing work after the paper was published has found the virus in nearly 98 percent of about 300 patients with the syndrome, said Dr. Judy A. Mikovits, the lead author of the paper.
XMRV is a retrovirus, a member of the same family of viruses as the AIDS virus. These viruses carry their genetic information in RNA rather than DNA, and they insert themselves into their hosts’ genetic material and stay for life.
Dr. Mikovits and other scientists cautioned that they had not yet proved that the virus causes the syndrome. In theory, people with the syndrome may have some other, underlying health problem that makes them prone to being infected by the virus, which could be just a bystander. More studies are needed to explain the connection.
But Dr. Mikovits said she thought the virus would turn out to be the cause, not just of chronic fatigue, but of other illnesses as well. Previous studies have found it in cells taken from prostate cancers.
“I think this establishes what had always been considered a psychiatric disease as an infectious disease,” said Dr. Mikovits, who is research director at the Whittemore Peterson Institute in Reno, a nonprofit center created by the parents of a woman who has a severe case of the syndrome. Her co-authors include scientists from the National Cancer Institute and the Cleveland Clinic
Dr. Mikovits said she and her colleagues were drawing up plans to test antiretroviral drugs — some of the same ones used to treat HIV infection to see whether they could help patients with chronic fatigue. If the drugs work, that will help prove that the virus is causing the illness. She said patients and doctors should wait for the studies to be finished before trying the drugs.
Dr. William Schaffner, an infectious disease expert at Vanderbilt University said the discovery was exciting and made sense.
“My first reaction is, ‘At last,’ ” Dr. Schaffner said. “In interacting with patients with chronic fatigue syndrome, you get the distinct impression that there’s got to be something there.”
He said the illness is intensely frustrating to doctors because it is not understood, there is no effective treatment and many patients are sick for a long time.
He added, “This is going to create
an avalanche of subsequent studies.” End.
Again CFS/ME associated with a chronic viral infection
•herpes viruses (especially Epstein-Barr virus, cytomegalovirus and HHV-6)
•enteroviruses (polioviruses, Coxsackie viruses, echoviruses)
•parainfluenza virus 5 (PIV-5)
•parvovirus B19
•various retroviruses
In January 2010,
another research team found no evidence of XMRV in 186
patients with chronic fatigue syndrome in the United
Kingdom. A third study, published earlier this month,
also failed to identify XMRV in 170 patients.
The German study didn't look into chronic fatigue syndrome, and it didn't involve the blood or prostate tissue, as other studies have. Instead, researchers tested respiratory-tract secretions from healthy controls plus 3 different categories of people with respiratory-tract infections (RTIs): those with no underlying conditions, those with underlying chronic obstructive pulmonary disease (COPD), and those on immunosuppressive medications because of a transplant.
They found XMRV in:
- 3.2% of controls
- 2.3% of those with RTIs & no underlying conditions
- 2.3% of those with RTIs & COPD
- 9.9% of
those on immunosuppressive drugs
http://www.ncbi.nlm.nih.gov/pubmed/19959199
Xenotropic murine leukemia virus related virus susceptible to AZT
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0011738
Apobec 3G Efficiently Reduces Infectivity of the Human Exogenous Gammaretrovirus XMRV
Kristin Stieler, Nicole Fischer
PlosOne, 2010 July 23
http://www.ncbi.nlm.nih.gov/pubmed/20576103
Identification of viral infections in the prostate and evaluation of their association with cancer.
Martinez-Fierro ML, Leach RJ, Gomez-Guerra L, Garza-Guajardo R, Pais-Johnson T, Beuten J, Morales-Rodriguez IB, Hernandez-Ordonez MA, Calderon-Cardenas G, Ortiz-Lopez R, Rivas-Estilla AM, Ancer-Rodriguez J, Rojas-Martinez A.
BMC Cancer. 2010 Jun 24
http://www.ncbi.nlm.nih.gov/pubmed/20507757
Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract.
Fischer N, Schulz C, Stieler K, Hohn O, Lange C, Drosten C, Aepfelbacher M.
Emerg Infect Dis. Epub ahead of print 2010 Jun
http://jvi.asm.org/cgi/content/abstract/84/13/6288?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=arnold&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Evaluation of Cellular Determinants Required for In Vitro Xenotropic Murine Leukemia Virus-Related Virus Entry into Human Prostate Cancer and Noncancerous Cells
Sushma Bhosle,1 Suganthi Suppiah,1 Ross Molinaro,1 Yuying Liang,1 Rebecca Arnold,2 William Diehl,1 Natalia Makarova,3 Jerry Blackwell,3 John Petros,1,2,5 Dennis Liotta,4 Eric Hunter,1,6 and Hinh Ly1*
Journal of Virology, July 2010. (published ahead of print 21 April 2010)
http://www.ncbi.nlm.nih.gov/pubmed/20507233
Characterization of retroviral and lentiviral vectors pseudotyped with XMRV envelope glycoprotein.
Sakuma T, Ravin SS, Tonne JM, Thatava T, Ohmine S, Takeuchi Y, Malech HL, Ikeda Y.
Hum Gene Ther. Epub ahead of print 2010 May 27.
http://www.ncbi.nlm.nih.gov/pubmed/20504941
Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with XMRV.
Metzger MJ, Miller AD.
J Virol. Epub ahead of print 2010 May 26.
http://oham.cancer.gov/objects/pdf/2010ICMAOI_Program_Book.pdf
http://www.capconcorp.com/meeting/12thICMAOI/agenda.asp
Repeated Detection of Infectious Xenotropic Murine Virus-Related Virus (XMRV) in Human Neoplasia and Neuroimmune Diseases
Abstract from 12th International Conference On Malignancies In AIDS And Other Acquired Immunodeficiencies (ICMAOI)
April 26-27, 2010
http://www.ncbi.nlm.nih.gov/pubmed/20421928
Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus.
Kim S, Rusmevichientong A, Dong B, Remenyi R, Silverman RH, Chow SA.
PLoS One. 2010 Apr 20
http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0009948
Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome
Ila R. Singh1*, John E. Gorzynski1, Daria Drobysheva1, Leda Bassit2, Raymond F. Schinazi2
Plosone, April 1, 2010
http://www.ncbi.nlm.nih.gov/pubmed/20371060
XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH.
Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, Ly H, Molinaro RJ, Blackwell JL, Petros JA.
Urology. 2010 April
http://jvi.asm.org/cgi/content/abstract/84/5/2556
Xenotropic Murine Leukemia Virus-Related Virus Establishes an Efficient Spreading Infection and Exhibits Enhanced Transcriptional Activity in Prostate Carcinoma Cells ,
Jason J. Rodriguez and Stephen P. Goff*
Journal of Virology, March 2010 (published online 16 December 2009)
http://jvi.asm.org/cgi/content/abstract/JVI.00134-10v1
Inhibition of Xenotropic Murine Leukemia Virus-Related Virus by APOBEC3 Proteins and Antiviral Drugs
Tobias Paprotka, Narasimhan J. Venkatachari, Chawaree Chaipan, Ryan Burdick, Krista A. Delviks-Frankenberry, Wei-Shau Hu, and Vinay K. Pathak*
J. Virol. June 2010 (Published ahead of print 24 March 2010)
http://www.ncbi.nlm.nih.gov/pubmed/19959199
Xenotropic murine leukemia virus-related virus is susceptible to AZT.
Sakuma R, Sakuma T, Ohmine S, Silverman RH, Ikeda Y.
Virology, 2010 Feb 5 (Epub 2009 Dec 2)
http://jvi.asm.org/cgi/content/short/84/4/1874
The Prostate Cancer-Associated Human Retrovirus XMRV Lacks Direct Transforming Activity but Can Induce Low Rates of Transformation in Cultured Cells
Michael J. Metzger, Christiana J. Holguin, Ramon Mendoza, and A. Dusty Miller*
Journal of Virology, February 2010 (Published ahead of print 9 Dec 2009)
http://www.pnas.org/content/107/11/5166.abstract
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors
Harriet C. T. Grooma, Melvyn W. Yapa, Rui Pedro Galãob, Stuart J. D. Neilb, and Kate N. Bishopa,1
PNAS, 2010 Mar 16 (Epub 2010 Mar 1)
http://jvi.asm.org/cgi/content/abstract/JVI.01763-09v1
Androgen Stimulates Transcription and Replication of XMRV (Xenotropic Murine Leukemia Virus-Related Virus)
Beihua Dong and Robert H. Silverman*
J Virol. 2010 Feb (Epub 2009 Nov 11)
http://www.ncbi.nlm.nih.gov/pubmed/20142478
Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses.
Schlecht-Louf G, Renard M, Mangeney M, Letzelter C, Richaud A, Ducos B, Bouallaga I, Heidmann T.
Proc Natl Acad Sci U S A. 2010 Feb 23 (Epub 2010 Feb eight)
http://www.ncbi.nlm.nih.gov/pubmed/20110097
Host range and cellular tropism of the human exogenous gammaretrovirus XMRV.
Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, Fischer N.
Virology. 2010 Mar 30 (Epub 2010 Jan 27)
|
Paul van Meerendonk, arts
Biologisch Medisch Centrum
Amsterdamsestraatweg 544 A
3553 EN UTRECHT
Tel.: 030-2805089
Fax: 030-2805198
Tel.spreekuur: ma,di,do,vr
16.30-17.30
Tevens:
Lariksweg 28
8162 EG EPE
Tel.: 0578-610292
Fax: 0578-610270
E-mail:
p.meerendonk@planet.nl